The inhibitor of growth (ING) family proteins have been defined as candidate tumor suppressors. ING4 as a novel member of ING family has potential tumor-suppressive effects via multiple pathways. However, the therapeutic effect of adenovirus-mediated ING4 (Ad-ING4) gene transfer in human osteosarcoma is still unknown. In this study, we explored the in vitro and in vivo antitumor activity of Ad-ING4 in human osteosarcoma and its potential mechanism using a MG-63 human osteosarcoma cell line. We demonstrated that Ad-ING4 induced significant growth inhibition and apoptosis, upregulated the expression of P21, P27 and Bax, downregulated the Bcl-2 expression and activated Caspase-3 in MG-63 human osteosarcoma cells. Moreover, intratumoral injections of Ad-ING4 in athymic nude mice bearing MG-63 human osteosarcoma tumors significantly suppressed osteosarcoma xenografted tumor growth, increased the expression of P21, P27 and Bax, reduced the Bcl-2 and CD34 expression and microvessel density (MVD) in tumors. This retarded MG-63 osteosarcoma growth in vitro and in vivo in an athymic nude mouse model elicited by Ad-ING4 was closely associated with the increase in the expression of cell cycle-related molecules P21 and P27, decrease in the ratio of anti-to pro-apoptotic molecules Bcl-2/Bax followed by the activation of Caspase-3 leading to apoptosis via intrinsic apoptotic pathways, and the inhibition of tumor angiogenesis. Thus, our results indicate that Ad-ING4 is a potential candidate for human osteosarcoma gene therapy.
Introduction
Inhibitor of growth (ING) is a candidate tumor suppressor family including ING1, ING2, ING3, ING4 and ING5, which are involved in apoptosis, cell cycle regulation and DNA repair. ING4, a novel member of the ING family, was first isolated and characterized by Shiseki et al. (1) . Recently, ING4 has attracted much attention as a strong candidate tumor suppressor that plays an important role in oncogenesis, DNA repair, tumor growth, angiogenesis, migration and gene transcription regulation. ING4 has a functionally conserved plant homeo domain (PHD)-finger motif in the COOH-terminal region involved in chromatin Volume 14 Number 4 August 2015 Technology in Cancer Research & Treatment 2014 April 16. Epub ahead of print remodeling and subsequent gene transcriptional regulation (2, 3) . It also has a potential bipartite nuclear localization signal (NLS) domain in the middle region which is essential for nuclear localization of ING4 and its binding and functional interaction with p53 (4) . Previous studies showed that ING4 was dramatically downregulated in glioblastoma (5) , head and neck carcinoma (6) , hepatocellular carcinoma (7) , melanoma (8) and gastric carcinoma (9) , which was closely associated with tumor grade, metastasis and prognosis (5, 7, 8) . ING4 can significantly inhibit tumor cell growth and induce cell cycle alteration and apoptosis in different tumor types such as colorectal, glioblastoma, melanoma, hepatocellular, myeloma, lung and pancreatic carcinomas (1, 5, 8, (10) (11) (12) (13) and enhance chemosensitivity to doxorubicin and etoposide in HepG2 hepatocelluar carcinoma cells (10) . ING4 can also suppress the activity of NF-κB and HIF-1α leading to inhibition of tumor angiogenesis (5, 11) . Furthermore, ING4 can suppress the loss of contact inhibition elicited by MYCN or MYC (14) . More recently, it has been reported that ING4 can exhibit marked inhibitory effect on tumor cell spreading, migration and invasion (8, 12, 15) . Thus, ING4 is a potent tumor suppressor that exerts its tumor-suppressive effect via multiple pathways in a variety of tumor types.
Osteosarcoma is an aggressive malignant tumor primarily of children and young adults that is characterized by proliferation of malignant mesenchymal cells producing immature bone or osteoid (16, 17) . It is mainly treated by surgical excision or chemotherapy. Currently, long-term disease-free survival can be achieved in 60% to 70% of patients diagnosed with osteosarcoma (17) . Despite the improvement in the survival rates, the prognosis of unresectable or recurrent cases is still quite poor and novel treatment modalities are urgently needed (16, 18) . Gene therapy represents a new and promising approach for cancer treatment. Adenovirus harboring therapeutic gene has been used successfully for gene transfer in vitro and in vivo, which is one of the most promising vectors for gene therapy. A great deal of data have been accumulated, with non-replicating adenoviral vectors suggesting a reasonable safety profile in humans (19) . Therefore, replication-defective adenoviral vector encoding tumor suppressor gene may be a novel therapeutic modality for osteosarcoma.
Our previous studies showed that adenovirus-mediated ING4 (Ad-ING4) gene transfer significantly suppressed in vitro and in vivo lung and pancreatic carcinoma cell growth (12, 13) . However, adenovirus-mediated ING4 gene therapy for human osteosarcoma has not been reported. In this report, we were interested in assessing the therapeutic effect of Ad-ING4 against a human osteosarcoma cell line MG-63 in vitro and in vivo in an athymic nude mouse model and elucidating its underlying mechanism.
Materials and Methods

Adenoviral Vectors, Cell Lines, Reagents and Mice
The Ad-ING4 and Ad-GFP replication-incompetent adeno viral vectors were constructed in our laboratory (12) , Cell and Molecular Biology Institute, College of Medicine, Soochow University (Suzhou, China). The QBI-293A human embryonic kidney cell line was kindly provided by Prof. Jiang Zhong, Fudan University (Shanghai, China). The MG-63 human osteosarcoma cell line was purchased from the American Type Culture Collection (ATCC, Rockville, MD). The QBI-293A and MG-63 cells were cultured in RPMI1640 (GIBCO, Shanghai, China) supplemented with 10% fetal bovine serum (FBS) (Hyclone, Logan, UT), respectively. The Trizol was purchased from Invitrogen (Shanghai, China). The reverse transcriptase polymerase MuMLV was purchased from MBI (Shanghai, China). The polyclonal goat anti-ING4 antibody was purchased from Abcam (Shanghai, China). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) kit was purchased from Sigma (Shanghai, China). The Annexin V-PE/7-AAD apoptosis detection kit was purchased from BD Biosciences (Shanghai, China). The antibodies specific for P21, P27, Bcl-2, Bax, Caspase-3, β-actin and CD34 were purchased from Santa Cruz (Shanghai, China). The SuperEnhanced chemiluminescence detection kit was purchased from Applygen Technologies Inc. (Beijing, China). The UltraSensitive TM SP kit was purchased from Maixin (Fuzhou, China). The male athymic nude mice were obtained from Shanghai Experimental Animal Center (Shanghai, China) and maintained in the animal facility at Soochow University according to the animal research committee's guidelines of Soochow University.
Adenovirus-mediated ING4 Gene Transfer
The recombinant replication-incompetent adenovirus Ad-ING4 expressing ING4 and green fluorescent protein (GFP) and its control adenovirus Ad-GFP were prepared in our laboratory as previously described (12) . To assess the optimal multiplicity of infection (MOI) for a maximal infection and transgene expression in MG-63 tumor cells, the MG-63 human osteosarcoma cells were infected with Ad-GFP and Ad-ING4 at various MOIs (0, 1, 10, 25, 50, 100 and 200), respectively. The adenoviral infection efficiency was examined according to GFP expression by fluorescence micro scopy and flow cytometry. Furthermore, the ING4 transgene expression mediated by adenoviral infection in MG-63 tumor cells was determined by RT-PCR and Western blot analysis. Total cellular RNAs were extracted from Ad-ING4-or Ad-GFP-infected and uninfected MG-63 tumor cells with Trizol and first cDNA strand was reversely transcribed with RNA as template and Oligo d(T) 18 (5′-gcgtcgacatggatgatgggatgtatttggaac-3′) and ING4-R (5′-gcaagcttctatttcttcttccgttcttgggag-3′) as primers under conditions [1 cycle at 94C (2 min) and then 72C (10 min) followed by 35 cycles at 94C (50 sec), 58C (50 sec) and 72C (55 sec)]. All PCR reaction products were analyzed on 1% agarose gel electrophoresis with ethidium bromide staining. Total cellular lysates derived from Ad-ING4 or Ad-GFPinfected or uninfected MG-63 tumor cells were resolved by SDS-PAGE (12%) and subsequently transferred onto a polyvinylidene difluoride (PVDF) membrane. The membrane was blocked by incubation with 5% (w/v) nonfat dry milk in Tris-buffered saline containing 0.05% Tween 20 (TBST) for 1 hr at 37C. For Western blot analysis, the membrane was incubated with primary antibody polyclonal goat anti-ING4 (1:1000) in blocking solution for 1 hr at 37C. The membrane was washed with TBST and incubated with peroxidaseconjugated secondary antibody rabbit anti-goat IgG (1:3000) in blocking solution for 1 hr at 37C. The membrane were then washed and developed by use of a SuperEnhanced chemiluminescence detection kit. The protein bands were visualized after exposure of the membranes to Kodak X-ray film.
Cell Viability Assay
The cytotoxic effect of Ad-ING4 on MG-63 human osteosarcoma cells was determined by MTT assay. Briefly, the MG-63 tumor cells were dispensed in 96-well culture plate at a density of 1 3 10 4 cells per well and incubated at 37C. After 24 hrs' incubation, they were infected with Ad-ING4 (100 MOI) for the indicated time periods (0-4 days). The medium containing Ad-GFP (100 MOI) was used as a blank adenovirus control, whereas the medium containing PBS without Ad-ING4 or Ad-GFP was used as a cell control (PBS control). Before treatment and at different time points after treatment, the cells were incubated with 10 μl MTT (5 mg/ml) for 4 hrs at 37C. The formazan crystals in the cells were solubilized with stop solution and the plate was then read at 570 nm using a Microplate Reader Model 550 (BIO-RAD, Shanghai, China).
Flow Cytometric Analysis of Apoptosis
Ad-ING4-induced apoptosis in MG-63 human osteosarcoma cells was assessed by flow cytometric analysis using Annexin V-PE (early apoptotic marker)/7-AAD (late apoptotic marker) double staining following manufacturer's instructions. Briefly, the MG-63 tumor cells (1 3 10 6 ) were infected with Ad-ING4 or Ad-GFP at MOI of 100. The medium containing PBS without Ad-ING4 or Ad-GFP was used as a cell control (PBS control). Twenty four hours later, the Ad-ING4-or Ad-GFP-infected and uninfected MG-63 tumor cells were collected and washed with cold PBS, respectively. Then the cells were incubated at room temperature in the presence of 5 μl Annexin V-PE and 5 μl 7-AAD in 100 μl of 1X of binding buffer. After 15 min's incubation, 400 μl of 1X binding buffer was added and the apoptotic cells were analyzed by flow cytometry.
Western Blot Analysis
The MG-63 human osteosarcoma cells treated with Ad-ING4, Ad-GFP or PBS for 24 hrs were collected, washed with cold PBS and lysed in lysis buffer (1 3 10 7 cells/1 ml lysis buffer). Total cellular proteins were extracted and the protein concentration was determined BCA protein assay using spectrophotometer. To elucidate the molecular mechanism involved in Ad-ING4-induced growth inhibition and apoptosis in MG-63 osteosarcoma cells, the cellular lysates containing 100 μg of total protein were subjected to Western blot analysis as described above using primary antibodies specific for P21, P27, Bcl-2, Bax and Caspase-3, respectively.
Animal Studies
Male athymic nude mice (5 each group) were subcutaneously (s.c.) inoculated on their armpits of right anterior limbs with 2 3 10 6 MG-63 human osteosarcoma cells, and then monitored daily for tumor growth. Tumor volumes were measured with a caliper before and after treatment, and calculated by the formula, tumor size 5 ab 2 /2, where a is the larger and b is the smaller of the two dimensions. When the tumors grew up to a volume of around 0.2-0.3 cm 3 , the mice were intratumorally (i.t.) injected with Ad-ING4 [1 3 10 8 plaque forming units (pfu)], Ad-GFP (1 3 10 8 pfu) and PBS every other day for a total of 6 times, respectively. Tumor progression and regression were monitored. In addition, the tumor-bearing mice were sacrificed 2 weeks after injection with Ad-ING4, Ad-GFP or PBS, and the MG-63 human osteosarcoma xenografted tumors were removed, weighted, fixed by 10% neutral formalin and embedded in paraffin for Hematoxylin & Eosin (HE) staining and immunohistochemistry analysis.
Immunohistochemistry and MVD Counting
The expression of P21, P27, Bcl-2, Bax and CD34 in MG-63 human osteosarcoma xenografted tumors was tested by immunohistochemistry analysis using UltraSensitive TM SP kit. The presence of buffy or brown diaminobenzidine precipitates is indicative of positive reactivity for P21, P27, Bcl-2, Bax and CD34. MVD, detected by immunostaining for CD34, was determined as previously described by Weidner et al. (20) . Any endothelial cell cluster immunoreactive for CD34 clearly separated from adjacent microvessels was considered as a single countable vessel. Each value represents the number of positive cells or vessels counted at a high power view (3400) by microscopy. The mean value represents for the average number derived from five high-power fields of each case. 
Statistical Analysis
All data are presented as the means  SD. The significance of the difference between groups was evaluated by one-way and two-way repeated measures analysis of variance (ANOVA) and multiple comparisons with SPSS 10.0 software. A value of p  0.05 was considered statistically significant.
Results
Adenovirus-mediated ING4 Expression
To determine the optimal MOI for a maximal infection and transgene expression, the MG-63 human osteosarcoma cells were infected with Ad-GFP and Ad-ING4 at various MOIs (0, 1, 10, 25, 50, 100 and 200), respectively, and examined by fluorescence microscopy. As shown in Figure 1A , more than 90% of GFP expression was found in the MG-63 tumor cells infected with Ad-GFP or Ad-ING4 at MOI of 100 and above, whereas the GFP expression was not found in the uninfected MG-63 control cells. The data was also confirmed by flow cytometric analysis ( Figure 1B ). Therefore, we selected a MOI of 100 as an optimal dose for adenoviral infection of MG-63 human osteosarcoma cell line in the following experiments. To further assess adenovirus-mediated ING4 expression, total cellular RNAs and lysates extracted from the Ad-ING4-or Ad-GFP-infected and uninfected MG-63 human osteosarcoma cells were subjected to RT-PCR and Western blot analysis. As shown in Figure 1C and 1D, a significant amount of ING4 expression was found in the Ad-ING4-infected MG-63 tumor cells, but not in the Ad-GFP-infected MG-63 cells and uninfected MG-63 control cells. These results indicate that transgene ING4 mediated by adenovirus is expressed in the Ad-ING4-infected MG-63 human osteosarcoma cells at both the transcriptional and translational levels.
Ad-ING4 Suppresses In Vitro and In Vivo MG-63 Osteosarcoma Cell Growth
To assess its cytotoxic effect to osteosarcoma cells in vitro, the MG-63 human osteosarcoma cells were cultured in presence or absence of Ad-ING4 (100 MOI). The tumor cell growth was examined daily for 4 days using MTT assay. Ad-ING4 treatment significantly inhibited the MG-63 tumor cell growth in a time-dependent manner, compared with the Ad-GFP-and PBS-treated control group (p  0.05) (Figure 2A ), indicating that transgene ING4 expression efficiently inhibits in vitro MG-63 human osteosarcoma cell growth. To further investigate its in vivo antitumor effect, the athymic nude mice (5 mice/group) bearing MG-63 human osteosarcoma tumors were intratumorally (i.t.) injected with Ad-ING4 (1 3 10 8 pfu), Ad-GFP (1 3 10 8 pfu) or PBS every other day for a total of 6 times. The tumor growth in vivo was monitored daily, and tumor volume and weight were measured. As shown in Figure 2B -2D, the in vivo MG-63 human osteosarcoma tumor growth was significantly retarded in Ad-ING4-treated group, compared with Ad-GFP-and PBStreated control group (p  0.05), indicating that adenovirusmediated ING4 expression also potentially suppresses in vivo in an athymic nude mouse model MG-63 human osteosarcoma tumor growth.
Ad-ING4 Induces MG-63 Osteosarcoma Cell Apoptosis
To explore the mechanism by which Ad-ING4 suppresses in vitro and in vivo MG-63 osteosarcoma cell growth, the MG-63 human osteosarcoma cells were treated with Ad-ING4, Ad-GFP or PBS for 24 hrs and harvested for staining with Annexin V-PE (early apoptotic marker) and 7-AAD (late apoptotic marker), and the apoptotic cells were then analyzed by flow cytometry. As shown in Figure 3 
Ad-ING4 Alters P21, P27, Bcl-2, Bax and Cleaved Caspase-3 Expression
To address the molecular mechanism involved in Ad-ING4induced growth inhibition and apoptosis in MG-63 tumor cells, the expression of cell cycle-and apoptosis-related proteins such as P21, P27, Bcl-2, Bax and Caspase-3 in Ad-ING4-infected MG-63 human osteosarcoma cells was determined by Western blot analysis. As shown in Figure 4A activation of Caspase-3 (Cleaved Caspase-3) was found in Ad-ING4-treated MG-63 tumor cells. To confirm the underlying mechanism, the in vivo expression of P21, P27, Bcl-2 and Bax in MG-63 osteosarcoma xenografted tumors was further assessed by immunohistochemistry analysis. As shown in Figure 4B and 4C, the expression of P21, P27 and Bax in the Ad-ING4-treated group was significantly upregulated, while the Bcl-2 was significantly downregulated, compared with Ad-GFP-and PBS-treated control group, which was consistent with above Western blot analysis. These results indicate that Ad-ING4 suppresses in vitro and in vivo MG-63 osteosarcoma cell growth and induces apoptosis closely associated with the upregulation of cell cycle-related molecules P21 and P27, and the decrease in the ratio of anti-to pro-apoptotic molecules Bcl-2/Bax followed by the activation of Caspase-3.
Ad-ING4 Reduces Tumor Vessel CD34 Expression and MVD
The positive expression of CD34 was mainly presented as brownish yellow or brownish granules in vascular endothelial cells. In all MG-63 human osteosarcoma xenografted tumor collected, the CD34 expression of vascular endothelial cells in the Ad-ING4-treated group was weaker or less, compared with Ad-GFP-and PBS-treated control group ( Figure 5A) , indicating that Ad-ING4 downregulates the CD34 expression of MG-63 human osteosarcoma xenografted tumor vessels. In addition, the MVD ( Figure 5B human osteosarcoma xenografted tumor in an athymic nude mouse model.
Discussion
ING4 is a novel tumor suppressor that has been implicated in oncogenesis, cell cycle control, apoptosis, DNA repair, angiogenesis, migration and gene transcription regulation.
Recent studies have showed that ING4 can significantly induce growth inhibition, cell cycle alteration and apoptosis in a variety of tumors and sensitize HepG2 hepatocelluar carcinoma cells to DNA-damage agents such as doxorubicin and etoposide (10) . ING4 can suppress brain tumor angiogenesis through inhibiting activity of NF-κB leading to transcriptional repression of NF-κB-responsive genes such as IL-6, IL-8 and Cox-2 by physically interacting with the (21) . Additionally, Colla et al. reported that ING4 can suppress HIF-1α activity and its target gene NIP-3 expression in myeloma cells under hypoxic condition and consequently inhibit tumor angiogenesis (11) . ING4 as a critical modulator in HIF pathway can negatively regulate HIF activity by directly associating with the HIF prolyl hydroxylase, a Fe(II)-dependent oxygenase, in a chromatin-dependent manner (22, 23) . ING4 can also suppress tumor cell spreading, migration and invasion through colocalizing and interacting with liprin α1 at lamellipodia and downregulating the expression and activity of MMP-2 and MMP-9 (8, 12, 24) . Moreover, ING4 may cooperate with other tumor suppressors to induce tumor cell growth inhibition and apoptosis (25, 26) . These findings revealed that ING4 as a potent tumor suppressor negatively modulate tumor growth via multiple pathways.
Osteosarcoma is one of the malignant tumors with a poor prognosis, especially in relapsed or inoperable cases. Hence, the search for novel therapeutic modalities for osteosarcoma is of paramount importance. Gene therapy is an innovative and promising treatment for cancers, and is also currently being investigated for osteosarcoma (27) . Our previous studies showed that adenovirus-mediated ING4 (Ad-ING4) gene transfer resulted in significant growth inhibition and apoptosis in lung and pancreatic carcinoma cells (12, 13) . The therapeutic potential of adenovirus-mediated ING4 gene therapy for human osteosarcoma remains to be determined. Therefore, in this study, we assessed the tumor-suppressive effect of Ad-ING4 on MG-63 human osteosarcoma cells in vitro and in vivo in an athymic nude mouse model. We demonstrated that Ad-ING4 induced significant growth inhibition and apoptosis, upregulated the expression of P21, P27 and Bax, downregulated the Bcl-2 expression and activated Caspase-3 in MG-63 human osteosarcoma cells. Moreover, intratumoral injections of Ad-ING4 in athymic nude mice bearing MG-63 human osteosarcoma tumors significantly suppressed osteosarcoma xenografted tumor growth, increased the expression of P21, P27 and Bax, reduced the Bcl-2 and CD34 expression and MVD in tumors.
The activities of cyclins, cyclin-dependent kinases (cdk) and cdk inhibitors are necessary for cell cycle progression (28) . The activities of these cyclin/cdk complexes are negatively regulated by the cdk inhibitors through directly inhibiting cdk's activity and preventing their phosphorylation (28) . p21 is a member of Cip/Kip family belonging to cdk inhibitors, which can inhibit the activity of cyclin E-CDK2, cyclin D-CDK4 and cyclin B1/CDC2 complexes leading to G1 and G2/M arrest (29) (30) (31) . p27 as an another member of Cip/Kip family of cdk inhibitors can prevent the activation of cyclin E-CDK2, cyclin A-CDK2 and cyclin D-CDK4 complexes responsible for G1 arrest (32) . Bcl-2 family proteins are known to be key regulators of apoptosis and important determinants of cell fate (33) . Bcl-2 is an important anti-apoptotic protein containing four conserved BH domain, which hetero dimerizes with Bax and its overexpression protects cells from apoptosis induced by different stimuli (34) . Bax is a BH3 domain protein that promotes pore formation in the mitochondrial outer membrane leading to loss of mitochondrial integrity and the release into the cytosol of cytochrome c followed by the activation of Caspase-3 (34) (35) (36) . The ratio of anti-to pro-apoptotic molecules such as Bcl-2/Bax constitutes a rheostat that sets the threshold of susceptibility to apoptosis for the intrinsic pathway, which utilizes organelles such as the mitochondrion to amplify death signals (33, 34) . To explore the potential molecular mechanism, we assessed the expression of cell cycle-and apoptosis-related molecules such as P21, P27, Bcl-2, Bax and Caspase-3 in Ad-ING4infected MG-63 human osteosarcoma cells by Western blot analysis. We found that Ad-ING4 increased the expression of P21 and P27, decreased the ratio of Bcl-2/Bax and induced the activation of Caspase-3 in MG-63 osteosarcoma cells. Furthermore, the effect of Ad-ING4 on in vivo expression of P21, P27, Bcl-2 and Bax in MG-63 osteosarcoma xenografted The altered expression of P21, P27, Bcl-2, Bax and Cleaved Caspase-3 may closely account for the Ad-ING4-mediated in vitro and in vivo growth inhibition and apoptosis in MG-63 tumor cells. The progressive growth and metastasis of solid tumors is dependent upon the process of angiogenesis. It has been reported that ING4 can suppress tumor angiogenesis via downregulating the activity of NF-κB and HIF-1α (5, 11) . To investigate the effect of Ad-ING4 on tumor angiogenesis in our model, we analyzed the CD34 expression and MVD in MG-63 osteosarcoma xenografted tumors by immunohistochemistry. We demonstrated that Ad-ING4 downregulated CD34 expression and suppressed tumor angiogenesis in MG-63 osteosarcoma xenografted tumors, which may be another important mechanism involved in Ad-ING4mediated in vivo growth inhibition of MG-63 osteosarcoma xenografted tumor in an athymic nude mouse model.
Although intratumoral administration of Ad-ING4 showed significant tumor-suppressing effect in MG-63 human osteosarcoma s.c. xenografted tumor in athymic nude mice, the present animal model and the therapeutic approach still had some drawbacks. Intravenous injection as a systemic therapy may not only target the primary tumors but also target the metastatic tumors. Thus, we need to further evaluate the therapeutic efficacy of Ad-ING4's intravenous injection in primary/metastatic human osteosarcoma model in our future work, which will provide more relevant preclinical data. In addition, low gene transfection efficiency, especially in intravenous administration, is currently the most common therapeutic challenge in cancer gene therapy. Hence, we also need to develop a tumor-specific delivery system using carrier cells or nanotechnologies to enhance the transfection efficiency of Ad-ING4 and reduce the potential systemic toxicity.
Taken together, adenovirus-mediated ING4 gene transfer significantly induced in vitro and in vivo growth inhibition and apoptosis, upregulated P21, P27 and Bax, downregulated Bcl-2 and activated Caspase-3 in MG-63 human osteosarcoma cells, and reduced CD34 expression and MVD in MG-63 osteosarcoma xenografted tumors; this retarded tumor growth elicited by Ad-ING4 was closely associated with the upregulation of cell cycle-related molecules P21 and P27, decrease in the ratio of anti-to pro-apoptotic molecules Bcl-2/Bax followed by the activation of Caspase-3 leading to apoptosis via intrinsic apoptotic pathways, and the inhibition of tumor angiogenesis. These results indicate that Ad-ING4 is a potential candidate for human osteosarcoma gene therapy.
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